Advances in Hematological Malignancies
Recent years have witnessed remarkable progress in the field of hematological malignancies. Novel therapies such as targeted therapy, immunotherapies, and gene editing are revolutionizing the outlook for patients with blood cancers. Clinical trials continue to explore these innovative techniques, offering promise for more effective treatment option